Suchergebnisse
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Organon (OGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Organon (OGN) Lags Q2 Earnings Estimates
Organon (OGN) came out with quarterly earnings of $0.85 per share, missing the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $1 per share a year ago. These figures are
Compared to Estimates, Organon (OGN) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2026, Organon (OGN) reported revenue of $1.56 billion, down 2.3% over the same period last year. EPS came in at $0.85, compared to $1.00 in the year-ago quarter.
The
Organogenesis Q2 Earnings Call Highlights
Organogenesis (NASDAQ:ORGO) reported a sharp year-over-year decline in second-quarter revenue as the skin substitute market continued to adjust to coverage and payment changes from the Centers for
